Fetal and neonatal alloimmune thrombocytopenia: A management algorithm based on risk stratification

Obstetrics and Gynecology

Volumn 118, Issue 5, 2011, Pages 1157-1163

  Pacheco, Luis D ^{a,b,c,d,e,f,g}   Berkowitz, Richard L ^{a,b,c,d,e,f,g}   Moise, Kenneth J ^{a,b,c,d,e,f,g}   Bussel, James B ^{a,b,c,d,e,f,g}   McFarland, Janice G ^{a,b,c,d,e,f,g}   Saade, George R ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f Blood Center of Wisconsin   (United States)

^g University of Texas Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE;

ACNE; ASEPTIC MENINGITIS; BLOOD SAMPLING; CHILL; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG FEVER; DRUG INDUCED HEADACHE; FETUS BLOOD; FLUID RETENTION; FLUSHING; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; LOW BACK PAIN; MOOD CHANGE; MYALGIA; NAUSEA; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; OSTEOPOROSIS; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; TREATMENT RESPONSE; WHEEZING;

ALGORITHMS; BLOOD SPECIMEN COLLECTION; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; PERIPARTUM PERIOD; PREGNANCY; RISK ASSESSMENT; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 80054882966     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31823403f4     Document Type: Review

References (17)

1. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective study of 5,194 fetal blood samplings. Blood 1994;84:1851-6. (Pubitemid 24286135)
2. Bussel JB, Zabusky ME, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22-6.
3. Mao C, Guo J, Chituwo BM. Intraventricular hemorrhage and it's prognosis, prevention, and treatment in term infants. J Trop Pediatr.1999;45:237-40. (Pubitemid 29385260)
4. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer 2005;45:176-83. (Pubitemid 40993584)
5. Turner M, Bessos H, Fagge T, Harkness M, Rentoul F, Seymour J, et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005;45:1945-56. (Pubitemid 43971423)
6. Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44:1220-5. (Pubitemid 38989755)
7. Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low dose steroids to intravenous gamma-globulin. Am J Obstet Gynecol 1996;174: 1414-23. (Pubitemid 26165254)
8. Kanhai HH, Porcelijn L, van Zoeren D, Klumper F, Vië tor H, Meerman RH, et al. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families. Eur J Obstet Gynecol Reprod Biol 1996;68:67-73. (Pubitemid 26292793)
9. Silver RM, Porter TF, Branch DW, Esplin MS, Scott JR. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol. 2000;182:1233-8. (Pubitemid 30353317)
10. Pearson HA, Shulman NR, Marder VJ, Cone TE Jr. Isoimmune neonatal thrombocytopenic purpura: clinical and therapeutic considerations. Blood 1964;23:154-77.
11. Bonacossa IA, Jocelyn LJ. Alloimmune thrombocytopenia of the newborn: neurodevelopmental sequelae. Am J Perinatol 1996;36:426-31.
12. Berkowitz RL, Kolb EA, McFarland JG, Wissert M, Primani A, Lesser M. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006; 107:91-6.
13. Berkowitz RL, Lesser ML, McFarland JG, Wissert M, Hung C, Bussel JB. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia. Obstet Gynecol 2007;110:249-55. (Pubitemid 47356647)
14. Bussel JB, Berkowitz RL, Hung C, Kolb EA, Wissert M, Primiani A, et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 2010;203:135.e1-14.
15. Sainio S, Teramo K, Kekomaki R. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Transfus Med 1999;9:321-30.
16. Lemm G. Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy. Neurology 2002;59:S28-32. (Pubitemid 36076546)
17. Grillo JA, Gorson KC, Ropper AH, Lewis J, Weinstein R. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Neurology 2001;57:1699-701. (Pubitemid 33055492)